T1Detect: Learn why you should be screened

JDRF, the largest non-profit funder of type 1 diabetes (T1D) research is focused on finding cures for T1D. Until we do, the advancements we’re making every day help improve the lives of those living with this disease for a better today and tomorrow.

T1Detect, JDRF’s screening education and awareness program, will arm you with the information you need before and after getting screened for T1D autoantibodies. Until now, T1D symptoms and a diagnosis often come out of the blue. Today, families can use testing to begin to determine their T1D risk early, so they can have time to plan and prepare for T1D. Now that autoantibody testing is available to you, anyone at any age, even without family history of T1D, can begin to find out—before symptoms even occur—if they are at risk for developing T1D. The test is easy, simple and can help save lives.


A Big Step Toward Prevention

Being diagnosed with T1D means a lifetime of dependence on insulin and careful management to avoid dangerous blood-sugar highs and lows. JDRF has been working for decades to prevent and cure this disease and making this blood test available to everyone is a promising step towards that.

Because T1D starts long before insulin dependency, families will be able to prepare, develop a plan for further monitoring with their doctor and hopefully avoid serious and sometimes life-threatening conditions, such as diabetic ketoacidosis (DKA), along with possible hospitalization that can be more common at the onset of the disease. And that’s not all. JDRF-funded research is closer than ever to developing therapies that can intervene and disrupt the disease’s progress before insulin dependency even begins.

Knowing your test results can also be empowering. Confirming that you or a loved one are not at risk for T1D can give families peace of mind and ease uncertainty.

How it works

This test detects autoantibodies in your blood that, along with additional testing, may mean you are at risk for T1D. Unfortunately, rates of T1D are growing among all racial and ethnic groups, with the highest increase among Black and Hispanic youth. Many people don’t develop the disease until later in life — and upwards of 93% of people with T1D have no family history of the disease. That’s why this test is available for everyone.

Step 1

Create an account to sign up, see payment options and order a test kit to be sent to your home. Kits are $55, with the option to order a subsidized kit if you are unable to afford the full-priced cost.

Step 2

With an easy finger prick, provide a few, painless blood samples and send your test kit back to the lab.

Step 3

Receive your autoantibody results, explanations of what they mean and next steps through your account on the testing website.

Benefits of Screening

Screening reduces the risk of DKA and hospitalization at onset of symptoms.

DKA, a serious complication of T1D, can be life-threatening and studies show that the risk of DKA at diagnosis is significantly reduced for those screened for autoantibodies and monitored closely by a doctor, if positive.

Right now, promising clinical trials are testing therapies that could delay the onset of T1D for years after screening.

These potential therapies could hold off insulin dependency for up to three years, but only with early intervention which is possible thanks to screening.

Knowing your results gives peace of mind and time to prepare.

Many families feel blindsided by a T1D diagnosis. Knowing your autoantibody results before the onset of symptoms can give you time to prepare with your doctor and family.

Frequently Asked Questions (FAQs)

Why should I get screened for autoantibodies?  

Type 1 diabetes (T1D) starts years before you need to go on insulin and many people get diagnosed with T1D because of a dangerous event called Diabetic Ketoacidosis (DKA). We know that screening and education with specialized medical follow up, if needed, can minimize the risk of DKA at diagnosis and greatly improve your health outcomes. You could even benefit from ongoing clinical trials to prevent the disease or new therapies as they become available if you choose after consultation with your physician. Additionally – and equally important – if you have someone with T1D in your family, you are at an increased risk for developing T1D compared to someone without a known direct /immediate family connection. 

Who should get screened? 

If you have T1D, or someone in your family does, you or your family are at an increased risk for developing T1D. Even if you don’t have a relative with T1D, or have T1D yourself, ~93% of T1D diagnoses happen to people without a known family connection. Screening is also important for everyone of all ages. Although T1D is more commonly diagnosed in children, teens, and young adults, it can develop at any age.  

What is the screening test for? 

The test is for the presence of proteins in your blood called Islet Autoantibodies that are markers, similar to routine tests for breast, prostate, colon and other cancers, or other diseases such as heart disease through cholesterol screening. Our goal is to establish routine screening for T1D risk as is done for other diseases, while therapies that can truly change the course of disease progression are developed. Specifically, the test will look for the presence of 3 T1D specific markers: insulin autoantibodies (IAA), GAD autoantibodies (GADA), insulinoma-associated antigen-2 autoantibodies (IA-2A). The test will incorporate more markers in the future.  

Who will know about my screening results? 

When you register for a screening test-kit through our clinical lab partner, Enable Biosciences, you will have the option to share your results with your doctor and with JDRF. Any results shared with your doctor will become part of your or your family member’s healthcare record. When you opt-in to share your results with JDRF, you will be contacted with individualized support, resources, and education. Your personal information and results will be protected and will not be shared in any way without your permission. 

Order your screening test kit today

Prevention is Cure

The capability to delay T1D by three years is almost in our grasp. The next step after that: Delaying it indefinitely and curing it. By making screening for T1D available to everyone, we’ll be able to accelerate the development and testing of disease modifying therapies to stop the disease from progressing and prevent it. This is meaningful progress towards not just saving lives from dangerous early-diagnosis complications, but ultimately eliminating a lifetime of T1D burdens before they even begin.

That’s why screening and our research into possible preventions are so important — they are a pathway to curing T1D once and for all. And for those currently living with T1D, JDRF continues to pursue promising and real pathways to cure this disease after its onset, while offering support, therapies, and guidance for healthy management until that day comes.

Find out more about JDRF’s research programs here.

Already been screened?

If you’ve already been screened and are positive for T1D autoantibodies, you can see if you’re eligible for a clinical trial through our partners at TrialNet.

Are you a healthcare professional?

Visit our healthcare professional resource page to access both accredited and non-accredited opportunities for T1D screening education. 


This education was supported by a sponsorship from the following partners.


Testing kits, sample analysis, and test results are not distributed, collected, conducted, analyzed, or reported by JDRF. JDRF does not assume responsibility for testing outcomes or processes. Any sponsorship from JDRF is solely for the purposes of covering at home testing costs incurred by authorized testing labs. JDRF urges testing users to speak with their healthcare provider for additional information based on the outcomes of their tests.

A single autoantibody test alone is not sufficient to determine your T1D risk. It must be confirmed and complemented by other testing and advisement by a medical professional expert in T1D.

Due to current state regulations, testing kits are currently not available for distribution to addresses in New York, Pennsylvania and Maryland. We are working diligently with the lab to make testing kits accessible in these states as quickly as possible. Please check back frequently for updates, or email info@jdrf.org for more information.

You are now leaving the JDRF website.

You will be directed to JDRF’s clinical lab partner, Enable Biosciences, where you can order your at-home test kit directly.